RE:Look at the chart...Qccity1 wrote: In Feb 2021, Opsens has announced a bought deal offering at a price of 1.80$ per common share. The stock was at 1.97$ at the time. Take at the look at the stock chart after this deal...
Today's sell-off was a gift. The NASDAQ Biotech ETF is now up marginaly over the last 3 months. OPS is down about 34%.